Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ESPB on Remifentanil Consumption in Lumbar Spine Surgery
NCT06303557Completed
- Sponsor
- Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
- Start
- Jan 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in lumbar disc herniation (LDH) (2 arms), sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. Primary endpoint: Intraoperative remifentanil consumption. Started Jan 2024; status: completed.
02
Drugs
bupivacaine
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT06303557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06303557.